How long does it take to cure Kawasaki disease?

Written by Li Jiao Yan
Neonatology
Updated on September 25, 2024
00:00
00:00

Kawasaki disease, also known as mucocutaneous lymph node syndrome, has unclear etiology and pathogenesis. The primary pathological change is systemic vasculitis, frequently affecting the coronary arteries. Kawasaki disease is considered a self-limiting condition, with most cases having a good prognosis; recurrence occurs in 1% to 2% of affected children. If associated with coronary artery damage and not effectively treated, 15% to 25% of these cases can develop coronary artery aneurysms. Typically, coronary artery aneurysms resolve within two years of onset, but often leave residual arterial wall thickening and reduced elasticity. Large aneurysms do not disappear completely and can lead to thrombosis or stenosis. Kawasaki disease is also one of the main causes of acquired heart disease in children. Therefore, active and effective treatment of Kawasaki disease can result in recovery. However, if there is accompanying coronary artery damage, the prognosis can vary depending on the extent of the damage. Severe coronary artery damage might lead to long-term heart disease.

Other Voices

doctor image
home-news-image
Written by Li Jiao Yan
Neonatology
1min 52sec home-news-image

How many days does it take to be discharged from the hospital for Kawasaki disease?

Kawasaki disease is a disease with unclear pathogenesis and etiology. A major pathological change is systemic vasculitis, which commonly affects the coronary arteries. Typically, it presents with fever lasting from seven to fourteen days or longer, and antibiotics are ineffective in treatment. During the first through sixth weeks of the illness, complications such as pericarditis, myocarditis, endocarditis, and arrhythmias may occur. Coronary artery damage often occurs between the second and fourth weeks of the illness, and proactive and effective treatment of Kawasaki disease can prevent coronary complications. The acute phase generally involves symptomatic supportive care, prevention of platelet aggregation, fever reduction, and prevention of coronary artery damage. Treatment with intravenous immunoglobulin is recommended within the first ten days of onset. If the treatment is not effective, other special medications like steroids may be used, and the treatment duration is generally between two to four weeks. Thus, the pathogenesis of Kawasaki disease is uncertain, and its pathological process is prolonged. The specific timing of discharge depends on the child's condition. If the fever is controlled and no significant coronary artery damage is evident, and the condition is stable, then discharge is possible. However, post-discharge, follow-up should be conducted based on the child's specific condition. Therefore, the duration of hospitalization for Kawasaki disease is not fixed and depends on the child's condition and treatment response.

doctor image
home-news-image
Written by Quan Xiang Mei
Pediatrics
1min home-news-image

How to alleviate vomiting in Kawasaki disease

When children with Kawasaki disease experience vomiting, the first step is to refrain from eating and drinking, including water, for one to two hours after vomiting to avoid burdening the stomach and intestines. If vomiting subsides after fasting, there is no need for medication temporarily. However, if there is no significant relief and bloating is evident, it is necessary to treat for bowel movement and gas release. At this time, oral medications that aid in digestion, such as digestive tonics, are acceptable. If relief is still not achieved, intravenous fluid supplementation and medications that enhance gastrointestinal motility can be administered. Parents can also keep the abdomen warm and, centering around the navel, perform clockwise abdominal massages to help alleviate the symptoms of vomiting.

doctor image
home-news-image
Written by Yao Li Qin
Pediatrics
52sec home-news-image

Kawasaki disease causes

Kawasaki disease, also known as mucocutaneous lymph node syndrome, is an immune-mediated systemic vasculitis syndrome and a relatively common pediatric febrile rash disease. To date, the etiology of Kawasaki disease is not entirely clear. Extensive epidemiological and clinical observations suggest that Kawasaki disease may be an acute immune dysregulation caused by infectious factors. Genetic factors are also related to the occurrence of Kawasaki disease. Various bacteria, viruses, mycoplasma, and their metabolic products, such as superantigens produced by Streptococcus and Staphylococcus, are also related to the development of Kawasaki disease.

doctor image
home-news-image
Written by Zeng Hai Jiang
Pediatrics
44sec home-news-image

Kawasaki Disease and Purpura Differences

The clinical manifestations of Kawasaki disease include fever lasting more than five days, ineffective antibiotic treatment, rashes, transient swelling of the cervical lymph nodes, conjunctival congestion, strawberry tongue, cracked lips, hard swelling of fingers and toes, and desquamation around the nails and anal region during the recovery phase. Allergic purpura is mainly manifested by rashes, which are generally hemorrhagic rashes below the buttocks, symmetrical on the lower limbs, raised above the skin surface, and usually without fever. Besides rashes, allergic purpura can also involve joint pain, abdominal pain, or allergic purpuric nephritis among other conditions.

doctor image
home-news-image
Written by Li Jiao Yan
Neonatology
32sec home-news-image

Does Kawasaki disease cause a rash on the face?

The pathogenesis of Kawasaki disease is unclear, and the main pathological change is systemic vasculitis. Typically, the rash is a polymorphic erythema or a scarlatiniform rash, primarily occurring on the trunk. Generally, facial rashes are rare, but it's not entirely impossible for rashes to appear on the face. Therefore, if a baby develops a rash on the face without other infections, Kawasaki disease might also present this symptom.